Use of changes in plasma levels of human immunodeficiency virus type 1 RNA to assess the clinical benefit of antiretroviral therapy

The Journal of Infectious Diseases
I C MarschnerM S Saag

Abstract

Data from 1330 human immunodeficiency virus type 1 (HIV-1)-infected patients enrolled in seven antiretroviral treatment trials were analyzed to characterize the clinical benefit of treatment-mediated reductions in plasma HIV-1 RNA levels. The risk of a new AIDS-defining event or death was reduced proportionally to the magnitude of the reduction of the HIV-1 RNA level during the first 6 months of therapy. Pretherapy HIV-1 RNA levels were prognostic independently of on-therapy levels. In addition, the reduction in risk associated with any given reduction of the level of HIV-1 RNA did not vary by pretherapy level. Having either a reduction in HIV-1 RNA level or an increase in CD4+ lymphocyte count, or both, was associated with a delay in clinical disease progression. This indicates that patient prognosis should be assessed using both HIV-1 RNA and CD4+ lymphocyte responses to therapy.

Citations

Jul 27, 2001·Journal of Medical Virology·C BergerD Nadal
Mar 17, 2004·Current Infectious Disease Reports·Jason D. Barbour, Robert M. Grant
Nov 14, 1998·Disease-a-month : DM·H W HorowitzG P Wormser
Mar 10, 2000·Biochimica Et Biophysica Acta·A G Tomasselli, R L Heinrikson
Feb 11, 2005·The New England Journal of Medicine·Gillian D SandersDouglas K Owens
Aug 9, 2003·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·John SpritzlerUNKNOWN Adult AIDS Clinical Trials Group
Oct 6, 2000·AIDS Research and Human Retroviruses·A HolguínV Soriano
May 15, 2001·AIDS Research and Human Retroviruses·M NúñezV Soriano
Oct 29, 2000·AIDS Patient Care and STDs·M Núñez, V Soriano
Apr 15, 1999·AIDS·V SorianoJ García-Samaniego
Mar 17, 1999·Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology : Official Publication of the International Retrovirology Association·I C MarschnerD R Kuritzkes
Oct 2, 2008·HIV Medicine·B G GazzardUNKNOWN BHIVA Treatment Guidelines Writing Group
Mar 18, 2000·Antimicrobial Agents and Chemotherapy·C J PetropoulosJ M Whitcomb
Jun 1, 2011·PloS One·Vincent C MarconiUNKNOWN Infectious Disease Clinical Research Program (IDCRP) HIV Working Group
Jun 19, 2008·Annals of Internal Medicine·Gillian D SandersDouglas K Owens

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antivirals (ASM)

Antivirals are medications that are used specifically for treating viral infections. Discover the latest research on antivirals here.

Antivirals

Antivirals are medications that are used specifically for treating viral infections. Discover the latest research on antivirals here.